Last reviewed · How we verify

NCT03765905

Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,

Completed Last updated 6 December 2018
What this trial tests

trial testing study in Polycystic Ovary Syndrome in 80 participants. Completed in 1 February 2018.

Timeline
1 December 2017
Primary endpoint
1 February 2018
1 February 2018

Quick facts

Lead sponsorKaradeniz Technical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 December 2017
Primary completion1 February 2018
Estimated completion1 February 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karadeniz Technical University

Who can join

Adults 18 to 35, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate serum SCUBE-1 and SCUBE-3 levels in PCOS and non-PCOS cases compared with non-PCOS healthy controls with similar age and body mass index

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of study

Trials testing the same drug.

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other Karadeniz Technical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing